Plain-English translation of NCT06082518 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing hyperbaric oxygen therapy (HBOT)—a treatment where you breathe pure oxygen in a pressurized chamber—to see if it can help people with long COVID symptoms like fatigue and brain fog. About 40 people will participate, and researchers want to understand if this treatment works and whether people can stick with it. The therapy has been used safely for other conditions and may help reduce inflammation related to long COVID.
Many people experience long-term symptoms after COVID-19, including exhaustion and difficulty concentrating, and current treatments don't work well for everyone. This study exists to see if this treatment might offer relief and to figure out if it's practical to test it more widely.
You likely qualify if…
You likely don't qualify if…
You'll be randomly assigned to either start oxygen therapy right away or wait 60 days to begin. If you start immediately, you'll visit the clinic for daily oxygen treatments (20 to 40 sessions total). You'll have check-in appointments at enrollment, before treatment starts (if delayed), 4 weeks after your first treatment, and then every 2 months for a full year. Each visit includes assessments of your symptoms and how you're feeling, and you'll fill out a satisfaction survey after finishing treatment.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
Canada